Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SRNE
6026
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $9K | ﹤0.01% |
5,687
-37,819
| -87% | -$69.4K |
2014 Q4
11 quarters
|
|
|
PTVCA
6027
DELISTED
Protective Insurance Corporation Class A Common Stock
PTVCA
| $9K | ﹤0.01% |
375
| – | – |
2013 Q4
15 quarters
|
|
|
SYG
6028
DELISTED
SPDR MFS Systematic Growth Equity ETF of SSgA Active Trust
SYG
| $9K | ﹤0.01% |
+119
| New | +$8.75K |
2017 Q3
0 quarters
|
|
6029
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $9K | ﹤0.01% |
7,043
-48,937
| -87% | -$62.5K |
2013 Q3
16 quarters
|
|
|
TETF
6030
DELISTED
ETF Industry Exposure & Financial Services ETF
TETF
| $9K | ﹤0.01% |
500
| – | – |
2017 Q2
1 quarter
|
|
|
INTX
6031
DELISTED
Intersections, Inc.
INTX
| $9K | ﹤0.01% |
2,625
-478
| -15% | -$1.83K |
2013 Q2
17 quarters
|
|
|
EGLT
6032
DELISTED
Egalet Corporation
EGLT
| $9K | ﹤0.01% |
6,616
-37,749
| -85% | -$50.5K |
2014 Q1
14 quarters
|
|
|
ANTH
6033
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $9K | ﹤0.01% |
6,660
-4,174
| -39% | -$5.93K |
2014 Q1
14 quarters
|
|
|
CVO
6034
DELISTED
Cenevo, Inc.
CVO
| $9K | ﹤0.01% |
2,521
-1,662
| -40% | -$7.55K |
2013 Q2
17 quarters
|
|
|
HUNTU
6035
DELISTED
Hunter Maritime Acquisition Corp. Unit
HUNTU
| $9K | ﹤0.01% |
850
| – | – |
2017 Q2
1 quarter
|
|
6036
Anixa Biosciences
ANIX
$101M
| $8K | ﹤0.01% |
+3,012
| New | +$3.31K |
2017 Q3
0 quarters
|
|
6037
Broadwind
BWEN
$91.6M
| $8K | ﹤0.01% |
2,563
-43,803
| -94% | -$165K |
2013 Q4
15 quarters
|
|
6038
Cardiff Oncology
CRDF
$84M
| $8K | ﹤0.01% |
145
-884
| -86% | -$55.1K |
2013 Q3
16 quarters
|
|
6039
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.27M
| $8K | ﹤0.01% |
+150
| New | +$8.2K |
2017 Q3
0 quarters
|
|
6040
Innodata
INOD
$2.13B
| $8K | ﹤0.01% |
5,000
| – | – |
2013 Q2
17 quarters
|
|
6041
Professional Diversity Network
IPDN
$2.35M
| $8K | ﹤0.01% |
4
-10
| -71% | -$31.1K |
2017 Q1
2 quarters
|
|
6042
NetSol Technologies
NTWK
$70.9M
| $8K | ﹤0.01% |
2,176
-16
| -0.7% | -$67 |
2013 Q2
17 quarters
|
|
6043
Invesco S&P 500 Downside Hedged ETF
PHDG
$62.8M
| $8K | ﹤0.01% |
+320
| New | +$8.29K |
2017 Q3
0 quarters
|
|
6044
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.89B
| $8K | ﹤0.01% |
384
| – | – |
2017 Q2
1 quarter
|
|
6045
Yunhong Green CTI Ltd
YHGJ
$7.18M
| $8K | ﹤0.01% |
+190
| New | +$9.65K |
2017 Q3
0 quarters
|
|
|
NBEV
6046
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $8K | ﹤0.01% |
2,450
-64,180
| -96% | -$272K |
2017 Q1
2 quarters
|
|
|
LUB
6047
DELISTED
Luby's Inc.
LUB
| $8K | ﹤0.01% |
3,090
-22,444
| -88% | -$61.8K |
2013 Q4
15 quarters
|
|
|
DSLV
6048
DELISTED
VelocitySharesTM 3x Inverse Silver ETN linked to the S&P GSCI Silver Inverse Index ER
DSLV
| $8K | ﹤0.01% |
+300
| New | +$7.64K |
2017 Q3
0 quarters
|
|
6049
DELISTED
ProShares UltraPro 3x Crude Oil ETF
OILU
| $8K | ﹤0.01% |
+300
| New | +$6.44K |
2017 Q3
0 quarters
|
|
|
HK.WS
6050
DELISTED
Halcon Resources Corporation
HK.WS
| $8K | ﹤0.01% |
14,799
| – | – |
2016 Q3
4 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.